2018
Update on the Comprehensive Approach to Fragility Fractures
Cohn M, Gianakos A, Grueter K, Rosen N, Cong G, Lane J. Update on the Comprehensive Approach to Fragility Fractures. Journal Of Orthopaedic Trauma 2018, 32: 480-490. PMID: 30036208, DOI: 10.1097/bot.0000000000001244.Peer-Reviewed Original ResearchConceptsFragility fracturesAnabolic agentsDual-energy x-ray absorptiometry screeningFracture Liaison Service (FLS) modelNew anabolic agentsFirst-line treatmentFracture liaison serviceBone density lossAntiosteoporotic medicationAntiresorptive agentsNonpharmacologic treatmentsFracture careVitamin DSurgical historyTreatment optionsAntisclerostin antibodiesBone densityBone diseaseEffective treatmentLiaison servicePhysician extendersFracture healingPotential treatmentDensity lossTreatment
2015
Osteoporosis and Hip Fractures
Olgun D, Gianakos A, Jo J, Galmer L, Lane J. Osteoporosis and Hip Fractures. 2015, 141-158. DOI: 10.1007/978-3-319-19905-4_8.Peer-Reviewed Original ResearchHip fractureFragility fracturesFragility fracture risk factorsOsteoporosis-related fragility fracturesMajor public health concernFracture risk factorsFracture liaison serviceMajority of patientsOsteoporotic fragility fracturesResidual functional impairmentOsteoporotic hip fracturesPublic health concernOsteoporosis managementPatient mortalityRisk factorsPatient outcomesPharmacological strategiesFunctional impairmentLiaison serviceSubsequent fracturesGreater riskHealth concernHealthcare expendituresOsteoporosisBone evaluation